Abstract:Highlights•TSPAN31 is rarely studied in human malignant tumors and a little study had explored its function and mechanism.•This study found that the expression level of TSPAN31 was related to the clinical characteristics and prognosis of patients with gastric cancer.•This study found that TSPAN31 can regulate the proliferation, migration and apoptosis of gastric cancer cells.•This study found that expression level of TSPAN31, METTL1 and CCT2 was positive correlation in gastric cancer cells.•This study found that down-regulation of TSPAN31 could be partially reversed the promoting effect of high expression of METTL1 or CCT2 on malignant phenotype of gastric cancer cells.Gastric cancer (GC) is one of the most common human malignancies worldwide, but the molecular mechanism of GC has not been fully elucidated. Tetraspanin 31 (TSPAN31) has been rarely studied in human malignant tumors. This study aimed to investigate the effects of TSPAN31 on GC. We analyzed GC tissues through high-throughput sequencing technology and chose TSPAN31 with high expression. The expression of TSPAN31 in GC was analyzed through bioinformatics website and qRT-PCR. The protein level of TSPAN31 in GC tissues was determined by western blot and immunochemistry. The proliferation, migration, and apoptosis of GC cells were detected by the cell counting kit-8, transwell, and apoptosis experiments. METTL1 and CCT2 that may co-express with TSPAN31 were predicted by the GEPIA database, and analyzed the correlation between the expression levels of TSPAN31, METTL1 and CCT2. The results shows TSPAN31 was highly expressed in GC tissues, and high expression of TSPAN31 was found to result in poor prognosis of patients with GC. TSPAN31 could regulate the proliferation, migration and apoptosis of GC cells. The relative expression levels of TSPAN31, METTL1 and CCT2 in GC were positively correlated. Low expression of TSPAN31 could partially reverse the effect of high expression of METTL1 and CCT2 on the tumor progression of GC cells. In conclusion, TSPAN31 was highly expressed in GC tissues and led to poor prognosis of patients with GC. TSPAN31 may regulate the proliferation, migration, and apoptosis of GC cells. This regulatory mechanism may be achieved through co-expression with METTL1 and CCT2.

Expression of tetraspanin 1 in breast cancer and its mechanism in promoting the progression of breast cancer

The role of tetraspanins pan-cancer

Upregulation of TSPAN 12 is Associated with the Colorectal Cancer Growth and Metastasis

Bioinformatics analysis reveals TSPAN1 as a candidate biomarker of progression and prognosis in pancreatic cancer

TSPAN1 overexpression as an indicator of poor prognosis in estrogen receptor-positive breast cancer

TSPAN31 regulates the proliferation, migration, and apoptosis of gastric cancer cells through the METTL1/CCT2 pathway

Expression and Clinical Significance of TSPAN-1 and CORTACTIN in Colorectal Carcinoma

Tetraspanin 1 Promotes Epithelial-to-mesenchymal Transition and Metastasis of Cholangiocarcinoma Via PI3K/AKT Signaling

Expression of Tspan-1 in benign and malignant lesions of the colon

Migrasome regulator TSPAN4 shapes the suppressive tumor immune microenvironment in pan-cancer

Expression of TGF-β1 and the mechanism of invasiveness and metastasis induced by TGF-β1 in breast cancer

Significance of Expression of Thrombospondin- 1 and Receptor- CD36 in Hepatocellular Carcinoma

TSPAN4 is a Prognostic and Immune Target in Glioblastoma Multiforme

TSPAN7 Exerts Anti-Tumor Effects in Bladder Cancer Through the PTEN/PI3K/AKT Pathway

Decreased TSPAN1 Promotes Prostate Cancer Progression and is a Marker for Early Biochemical Recurrence after Radical Prostatectomy

Tetraspanin-8 Promotes Hepatocellular Carcinoma Metastasis by Increasing ADAM12m Expression.

Expression and function of transmembrane 4 superfamily proteins in digestive system cancers

Role of Tetraspanins in Liver Cancer

High TSPAN8 Expression in Epithelial Cancer Cell‐derived Small Extracellular Vesicles Promote Confined Diffusion and Pronounced Uptake

The role of Tetraspanins in digestive system tumor development: update and emerging evidence

Spatial Transcriptomic Profiling of Tetraspanins in Stage 4 Colon Cancer from Primary Tumor and Liver Metastasis